2008 Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G; Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group.
Am Heart J. 2008 Sep;156(3):520-6. Epub 2008 Jul 7.

2004 Hypertension and age over 70 years are the two most important risk factors for stroke in patients with atrial fibrillation
Halimi F, Leclercq JF, Bacquet P, Fiorello P, Attuel P.
Ann Cardiol Angeiol (Paris). 2004 Jan;53(1):18-22. French.

2003 Atrial vulnerability: a new protocol by bigeminy pacing
Attuel P, Halimi F, Fiorello P, Leclercq JF.
Ann Cardiol Angeiol (Paris). 2003 Aug;52(4):215-9. French.

2003 Bigeminy pacing: a new protocol to unmask atrial vulnerability.
Attuel P, Leclercq JF, Halimi F, Fiorello P, Stiubei M, Seing S.
J Cardiovasc Electrophysiol. 2003 Jan;14(1):10-5.